NCT00384683

Brief Summary

The goal of this clinical research study is to learn whether the inability of certain blood vessel cells (endothelial cells) to function properly may help researchers to predict who is at risk for complications after surgery and whether this dysfunction contributes to complications after surgery. This study will use a blood test to quantify the number of cells that are destined to become endothelial cells.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 5, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 6, 2006

Completed
12.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2019

Completed
Last Updated

September 24, 2019

Status Verified

September 1, 2019

Enrollment Period

13.3 years

First QC Date

October 5, 2006

Last Update Submit

September 20, 2019

Conditions

Keywords

Endothelial DysfunctionEndothelial CellsPerioperative OutcomeBlood Sample

Outcome Measures

Primary Outcomes (1)

  • Number of Patient Major Pulmonary Events (MPE)

    Baseline (entry in study) to end of study (estimated 1 year post-operative)

Secondary Outcomes (1)

  • Patient's Duration of intensive care unit / hospital length of stay

    Baseline to final day of hospitalization

Study Arms (1)

Endothelial Dysfunction

Participants are scheduled for major chest (lung or esophagus) surgery or are a healthy volunteer. A blood test will quantify the number of cells that are destined to become endothelial cells.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants is scheduled to have major chest (lung or esophagus) surgery or is a healthy volunteer.

You may qualify if:

  • Patients scheduled for major thoracic surgery (lobectomy, pneumonectomy, esophagectomy).
  • Patients 18 years of age or older.
  • Patients who have signed the consent form to participate in the study.
  • Patients must have been evaluated in the Preanesthesia Clinic or by a staff Anesthesiologist preoperatively.
  • All laboratory and diagnostic evaluations required or used to evaluate the patient in the Preanesthesia Clinic must be completed. All patients must be approved for surgery by the standards of the Preanesthesia Clinic.

You may not qualify if:

  • Refusal to participate in the study.
  • Patient is under age 18.
  • Patient is unwilling to sign consent.
  • Patient is unable to exercise (bedridden or wheel chair bound).
  • Patient is enrolled in another study deemed by the investigator to affect oxygen metabolic efficiency and not presently the standard of care at MDACC.
  • Any patient whose condition is deemed unsatisfactory for surgery after the preanesthetic evaluation.
  • Surgery canceled for any reason. The patient may reenter the study if surgery is rescheduled.
  • Patient has had a myocardial infarction within 3 months of visiting the Preanesthesia Clinic or presents with new or unstable angina.
  • Patient has a history of cerebrovascular accident or transient ischemic attacks within 3 months of visiting the Preanesthesia Clinic.
  • Patient has a history of pulmonary embolic event within 3 months of visiting the Preanesthesia Clinic.
  • Patient known to have acute or chronic deep vein thrombosis.
  • Pregnant patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples collected to measure number of circulating blood cells that become endothelial cells. During surgery a small sample of lung tissue collected, if available.

Study Officials

  • Reza-John Mehran, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2006

First Posted

October 6, 2006

Study Start

March 1, 2006

Primary Completion

June 5, 2019

Study Completion

June 5, 2019

Last Updated

September 24, 2019

Record last verified: 2019-09

Locations